Sylvie Bertholet

Sylvie Bertholet

GlaxoSmithKline - Needham / United Kingdom
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4371256
-
person_outline Sylvie Bertholet's MOST POPULAR ARTICLES
1-) Phagosomes are competent organelles for antigen cross-presentationM Houde, S Bertholet, E Gagnon, S Brunet, G Goyette, A Laplante, ...Nature 425 (6956), 402-406, 20039172003
2-) New horizons in adjuvants for vaccine developmentSG Reed, S Bertholet, RN Coler, M FriedeTrends in immunology 30 (1), 23-32, 20098152009
3-) CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania majorY Belkaid, E Von Stebut, S Mendez, R Lira, E Caler, S Bertholet, MC Udey, ...The Journal of Immunology 168 (8), 3992-4000, 20024192002
4-) Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantRN Coler, S Bertholet, M Moutaftsi, JA Guderian, HP Windish, SL Baldwin, ...PloS one 6 (1), e16333, 20114132011
5-) A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosisS Bertholet, GC Ireton, DJ Ordway, HP Windish, SO Pine, M Kahn, T Phan, ...Science translational medicine 2 (53), 53ra74-53ra74, 20103602010